Preliminary results of early clinical trials with the fully human anti-TNFalpha monoclonal antibody D2E7.


Current pharmacological treatments for rheumatoid arthritis (RA), including non-steroidal anti-inflammatory drugs (NSAIDs), disease modifying anti-rheumatic drugs (DMARDs), and corticosteroids, have been moderately successful in alleviating the discomforts associated with swollen, painful joints. However, conventional medical approaches to treatment have… (More)


2 Figures and Tables